CELLINTA LTD
D43/100Summary
CELLINTA LTD is an active private limited company (company number 12161294) incorporated on 16 August 2019, registered in London. Its registered activity is research and experimental development on biotechnology (SIC 72110). Latest micro accounts cover the period ending 31 December 2025, showing net assets of £0, with 0 employees on average. As micro-entity accounts, no profit and loss account is filed, so turnover and profit are not public.
By net assets it sits in the lower half of 603 comparable companies in London (median £440, upper quartile £92k).
Key dates
- Incorporated
- 16 August 20197 yrs ago
- Next accounts due
- 30 September 2027in 343 days
- Confirmation statement due
- 30 August 2027in 312 days
Due dates are expected from Companies House filing rules; confirm on the official register before relying on them.
Activity
- SIC 72110
- Research and experimental development on biotechnology
- Accounts type
- Micro Entity
- Size band
- MicroCompanies Act thresholds
Financials
| Period end | Net assets | Cash | Debtors | Creditors <1y | Turnover | Profit | Employees |
|---|---|---|---|---|---|---|---|
| 31 December 2025 | £0 | — | — | £0 | — | — | 0 |
| 31 December 2024 | £0 | — | — | £0 | — | — | 0 |
Figures as filed in iXBRL accounts at Companies House. "—" means the line was not reported in that filing; micro-entity accounts contain no profit and loss account.
Firmoscan score
| 50 | Starting scoreEvery scored company starts here |
| −15 | Negative net assetsNet assets £0 at 2025-12-31 |
| +8 | EstablishedIncorporated 2019-08-16 (7 years) |
| 43 | Score, grade D |
A transparent, rules-based score from filed data only: every point lists its evidence. It is not a credit rating or advice. How the score is computed.
Ownership and control
- Sv7 (Imf) Gp Llp
- owns 75–100% of shares
- holds 75–100% of voting rights
- can appoint or remove directors
- Dementia Discovery Gp Lp
- owns 75–100% of shares
- holds 75–100% of voting rights
- can appoint or remove directors
- Sv7 (Imf) Gp Llp
- owns 75–100% of shares
- holds 75–100% of voting rights
- can appoint or remove directors
- Professor Steve Pollard
- owns 25–50% of shares
- holds 25–50% of voting rights
- Prof Steven Michael Pollard
- owns 75–100% of shares
- holds 75–100% of voting rights
- can appoint or remove directors
Persons with significant control hold 25% or more of shares or voting rights. Smaller shareholdings are only listed in confirmation-statement documents.
Timeline
- Next accounts duein 343 days
- Confirmation statement duein 312 days
- Accounts period endNet assets £0 · micro accounts
- Accounts period endNet assets £0 · micro accounts
- Incorporated
Similar companies in London
- ALCHEMAB THERAPEUTICS LTDLondon · inc. Aug 2019
- OXILIO LIMITEDLondon · inc. Aug 2019
- SENZO HEALTH LIMITEDLondon · inc. Aug 2019
- AZOMICS LTDLondon · inc. Aug 2019
- CORNATURAL LTDLondon · inc. Aug 2019
- MOLECULES TO MEDICINES LTDLondon · inc. Sept 2019
All companies incorporated on 16 August 2019 · in Aug 2019.
Reminders for CELLINTA LTD
Get an email before each filing deadline — accounts and confirmation statement — so nothing is late.